Revolutionary Study Reveals How Genes and Lifestyle Together Influence Dilated Cardiomyopathy Risk

A recent study led by scientists from the Victor Chang Cardiac Research Institute has shed light on dilated cardiomyopathy (DCM), a significant cause of heart failure. They examined nearly 3,200 individuals affected by DCM, particularly focusing on a gene mutation in TTN.

What they found was striking: those with the TTN mutation were 21 times more likely to develop DCM compared to their relatives without the mutation. This new insight emphasizes the importance of genetic testing, which can be done through a simple blood test. According to the study published in the European Heart Journal, DCM impacts roughly one in every 250 people globally, or about 32 million individuals.

Beyond genetics, the research also highlighted lifestyle factors that influenced diagnosis timing. Factors such as being overweight or consuming excessive alcohol could lead to an earlier diagnosis of DCM. Interestingly, men with the mutation tend to show symptoms at a younger age than women.

“Our study reveals just how much mutations in this gene raise the risk of developing DCM. This knowledge allows doctors to monitor at-risk patients more closely,” says Professor Fatkin of the Victor Chang Institute. “Living a healthy lifestyle can help delay or prevent the onset of DCM, encouraging those at risk to prioritize their health.”

This finding aligns with previous research indicating that lifestyle changes can significantly reduce health risks. Data from the American Heart Association suggests that maintaining a balanced diet and regular exercise can lower heart disease rates. In fact, studies show that 80% of heart disease can be prevented through these lifestyle adjustments.

Additionally, clinical factors such as high blood pressure or type 2 diabetes also increase the risk of developing DCM. Those with a history of atrial fibrillation double their chances of getting the disease. This underscores the need for further research. Experts are eager to explore whether early medication could help those with TTN mutations before symptoms appear.

Professor Fatkin notes, “There are still many questions to address. Should we give treatments earlier? Could we delay or prevent DCM entirely?” These are critical considerations for future studies.

This groundbreaking research involved a robust international team, examining families from countries like Australia, the UK, and South Korea. The size of the study is unprecedented, paving the way for more effective strategies in managing DCM.

As we navigate these findings, it’s clear that a combination of genetics and lifestyle plays a crucial role in DCM development. Staying informed and making healthy choices can significantly impact heart health.

For further information on heart health and related studies, visit the Victor Chang Cardiac Research Institute.

For the full study, check the European Heart Journal

.



Source link

Cardiomyopathy, Heart, Heart Disease, Alcohol, Blood, Blood Pressure, Cardiac Arrest, Diabetes, Exercise, Gene, Genetic, Heart Failure, High Blood Pressure, Mutation, Research